The White House wants the drug industry to know it is playing hardball on drug pricing. Just two months after unveiling a drug pricing plan, which some said raised more questions than answers, the Trump administration is mounting a pressure campaign meant to stem the tide of rising drug prices, as the administration hashes out what policy changes it will pursue. In recent weeks, Trump’s HHS has dangled the threat of further regulation — including drug importation — over drug...